CAS RN: 4357-57-7
9-BroMoacridine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260227
100mg / 250mg / 1g / 5g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 4357-57-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥97%
0
Out of Stock
Shanghai
Inquiry
4357-57-7 / 9-bromoacridine
Standard CAS: 4357-57-7
Multi CAS: No
Basic Information
copy
CAS
4357-57-7 copy
Multi CAS
No copy
Molecular Formula
BC13H8Rn copy
Molecular Weight
258.110000 copy
Exact Mass
256.984010 copy
InChI
InChI=1S/C13H8BrN/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H copy
InChIKey
NNTFCRCMYKVMPU-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
14 copy
H-bond acceptors
1 copy
Molar refractivity
66.95 copy
TPSA
12.89 copy
LogP / Solubility
WLOGP
4.15 copy
MLOGP
3.66 copy
XLogP3
4.2 copy
Consensus LogP
4 copy
Log S (ESOL)
-4.75 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-4.67 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.78 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.35 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy